Because CSF Aβ40 was not associated with PET measures of either Aβ or tau (Fig. 1a, b) and is not elevated in AD [21–29], its use as a normalization variable is unlikely to bias estimates of CSF pTau. Here, MAPT is linked to Alzheimer disease.